Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 8/2010

01-08-2010 | Translational Research and Biomarkers

Society of Surgical Oncology Presidential Address: The War on Cancer—Shifting from Disappointment to New Hope

Author: William G. Cance, MD

Published in: Annals of Surgical Oncology | Issue 8/2010

Login to get access

Excerpt

First of all, it has been a singular honor to be your President for the past year. It has been a wonderful journey with the SSO since I first began working on the Program Committee in 1993. I have learned from outstanding mentors during this time and have watched our Society grow not only in membership, but also redefining itself as we seek to broaden our outreach across all surgeons across the world. We keep getting better and I am confident that our organization will continue on the paths set by my predecessors. …
Literature
1.
Burris HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997;15(6):2403–13.PubMed
2.
Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 2007;25(15):1960–6.CrossRefPubMed
3.
4.
Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994;124(4):619–26.CrossRefPubMed
5.
Golubovskaya VM, Kweh FA, Cance WG. Focal adhesion kinase and cancer. Histol Histopathol. 2009;24(4):503–10.PubMed
6.
Cance WG, Golubovskaya VM. Focal adhesion kinase versus p53: apoptosis or survival? Sci Signal. 2008;1(20):pe22.CrossRefPubMed
7.
Burdelya LG, Krivokrysenko VI, Tallant TC, et al. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science. 2008;320(5873):226–30.CrossRefPubMed
Metadata
Title
Society of Surgical Oncology Presidential Address: The War on Cancer—Shifting from Disappointment to New Hope
Author
William G. Cance, MD
Publication date
01-08-2010
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 8/2010
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-0987-2

Other articles of this Issue 8/2010

Annals of Surgical Oncology 8/2010 Go to the issue

Gastrointestinal Oncology

Improved Long-Term Quality of Life in Patients with Laparoscopy-Assisted Distal Gastrectomy with Jejunal Pouch Interposition for Early Gastric Cancer

Colorectal Cancer

Preoperative Staging with Chest CT in Patients with Colorectal Carcinoma: Not as a Routine Procedure

Translational Research and Biomarkers

Epigenetic Inactivation of the Thyroid Hormone Receptor β1 Gene at 3p24.2 in Lung Cancer

Hepatobiliary Tumors

Sequenced Chemotherapy and Surgery for Potentially Resectable Colorectal Liver Metastases: A Debate Over Goals of Research and an Approach While the Jury Remains Out

Gastrointestinal Oncology

Prognostic Significance of Perineural Invasion in Patients with Gastric Cancer Who Underwent Curative Resection

Hepatobiliary Tumors

Predictive Factors for Hypertrophy of the Future Remnant Liver After Selective Portal Vein Embolization